Unraveling the Determinants of Protrusion Formation

Table 6

Effects of Rho kinase/myosin inhibitors on the prevalence of factor 5 features^a.

Tukey grouping					Mean	Combination of agents
A					0.830	H1152p, ROCK inhibitor (20.2 μM)
A	B				0.525	SPC16524, MLC kinase inhibitor (680 μM)
A	B	C			0.353	H1152p (5.02 μM)
	B	C	D		0.072	Control (PMA + LPA)
		C	D	E	−0.195	SPC16524 (170 μM)
		C	D	E	−0.371	Blebbistatin (0.8 μM)
			D	E	−0.405	Control (untreated)
				E	−0.592	Blebbistatin (0.2 μM)

^aMeans with the same letter are statistically indistinguishable at the level 𝑃<0.05.